Yew Bio-Pharm Group, Inc. Operating Lease Right-of-Use Assets
Yew Bio-Pharm Group, Inc. had Operating Lease Right-of-Use Assets of $292.61 thousand as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2021-11-15
- 2021-09-30: Operating Lease, Right-of-Use Asset $292.61K.
- 2021-06-30: Operating Lease, Right-of-Use Asset $306.42K.
- 2021-03-31: Operating Lease, Right-of-Use Asset $317.88K.
- 2020-12-31: Operating Lease, Right-of-Use Asset $333.40K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2021-09-30 | $292.61K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $306.42K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $317.88K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $333.40K 10-Q · filed 2021-11-15 |
| 2020-09-30 | $337.96K 10-Q · filed 2020-11-13 |
| 2020-06-30 | $339.08K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $382.42K 10-Q · filed 2020-06-29 |
| 2019-12-31 | $399.82K 10-K · filed 2021-03-30 |
| 2019-09-30 | $218.19K 10-Q · filed 2020-11-13 |
| 2019-06-30 | $297.73K 10-Q · filed 2019-08-13 |
| 2019-03-31 | $349.79K 10-Q · filed 2019-05-22 |